Provided by Tiger Trade Technology Pte. Ltd.

FibroBiologics

1.10
-0.0450-3.95%
Volume:27.21K
Turnover:30.17K
Market Cap:7.29M
PE:-0.23
High:1.13
Open:1.12
Low:1.05
Close:1.14
52wk High:10.33
52wk Low:0.6201
Shares:6.66M
Float Shares:5.42M
Volume Ratio:0.68
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7656
EPS(LYR):-8.3501
ROE:-660.08%
ROA:-95.77%
PB:1.57
PE(LYR):-0.13

Loading ...

FibroBiologics files U.S. patent application covering, GLP-1, other peptides

TIPRANKS
·
Yesterday

FibroBiologics Files Patent for Engineered Cells Designed to Produce GLP-1 Inside Body

Reuters
·
Yesterday

Fibrobiologics Files Patent Application for Technology Designed to Produce Glp-1 and Other Therapeutic Peptides Inside the Body

THOMSON REUTERS
·
Yesterday

FibroBiologics announces grant of European patent

TIPRANKS
·
Sep 29

FibroBiologics Wins European Patent for Enhancing Fibroblast Therapeutic Activity

Reuters
·
Sep 29

FibroBiologics Shareholders Approve Potential Warrant-Driven Share Issuance

TIPRANKS
·
Sep 19

FibroBiologics Closes USD 0.5 Million Private Placement with Chief Scientific Officer

Reuters
·
Sep 17

Fibrobiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer

THOMSON REUTERS
·
Sep 17

Press Release: FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer

Dow Jones
·
Sep 17

Fibrobiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing

THOMSON REUTERS
·
Sep 03

FibroBiologics Wins New US Patent Covering Topical Fibroblast-Based Wound Healing Therapy

Reuters
·
Sep 03

FibroBiologics Files Form 3 for Director Leigh Steinberg

Reuters
·
Sep 02

Fibrobiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media

THOMSON REUTERS
·
Sep 01

FibroBiologics Ships Third Cywc628 Batch to Australia for Phase 1/2 Diabetic Foot Ulcer Trial

Reuters
·
Aug 27

Fibrobiologics Releases Third Batch of Cywc628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

THOMSON REUTERS
·
Aug 27

FibroBiologics Regains NASDAQ Compliance on $1 Minimum Bid-Price Rule

Reuters
·
Aug 26

Fibrobiologics Regains Compliance with NASDAQ Trading Rules

THOMSON REUTERS
·
Aug 26

FibroBiologics Appoints Sports Agent Leigh Steinberg to Board

Reuters
·
Aug 24

Fibrobiologics Appoints Leigh Steinberg to Board of Directors

THOMSON REUTERS
·
Aug 24

FibroBiologics Says Australia Accepts Patent Application for CBD Adjuvant Therapy in Degenerative Disc Disease

Reuters
·
Aug 20